Decoding the Limits of Deep Learning in Molecular Docking for Drug Discovery

Key Points

• Deep learning reveals limitations in molecular docking for drug discovery, indicating a need for critical evaluation.
• Key evidence shows emerging deep learning techniques may not always enhance molecular docking outcomes significantly.
• Assessment using structure-based molecular docking methodologies uncovers challenges in dynamics and accuracy.
• This research highlights potential issues in deep learning approaches applied to drug discovery, calling for careful consideration.